Literature DB >> 10641147

Effects of vanadate, insulin and fenugreek (Trigonella foenum graecum) on creatine kinase levels in tissues of diabetic rat.

S Genet1, R K Kale, N Z Baquer.   

Abstract

The in vivo effects of insulin, and other insulino mimetic agents like vanadate and fenugreek (T. foenum graecum) were followed on the changes in the activities of creatine kinase in heart, skeletal muscle and liver of experimental diabetic rats. As compared to control rats, creatine kinase activities were found to decrease significantly in the tissues during experimental diabetes. All the antidiabetic compounds used namely, insulin, vanadate and Fenugreek seed powder normalised the decreased activities to almost control values. The effects of insulin and vanadate were comparable in restoring normoglycemia and the creatine kinase activities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10641147

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  4 in total

1.  Effects of free radicals on cytosolic creatine kinase activities and protection by antioxidant enzymes and sulfhydryl compounds.

Authors:  S Genet; R K Kale; N Z Baquer
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

2.  Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonellafoenum graecum).

Authors:  Solomon Genet; Raosaheb K Kale; Najma Z Baquer
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

Review 3.  Nanotechnological approaches for the development of herbal drugs in treatment of diabetes mellitus - a critical review.

Authors:  Saritha Marella; Naga Venkata Krishna Vara Prasad Tollamadugu
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

Review 4.  Traditional Indian medicines used for the management of diabetes mellitus.

Authors:  Syed Ibrahim Rizvi; Neetu Mishra
Journal:  J Diabetes Res       Date:  2013-06-05       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.